We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Merck & Co. is suing German biotech and chemical giant Merck KGaA in federal court for alleged trademark infringement as part of a larger battle between the two companies over the rights to the Merck name. Read More
The Biotechnology Innovation Organization and a Duchenne patient advocacy group are joining forces to help drugmakers design clinical studies with patient input and drive rare-disease research. Read More
Patent cases involving payments to delay generic competition have dropped 27 percent following a 2013 challenge to the practice, according to the Federal Trade Commission. Read More
Roche has settled its legal feud over Tarceva with Glenmark Pharmaceuticals, with both sides agreeing to drop lawsuits over patent rights in India. Read More
Drugmakers that have not started complying with worldwide track and trace regulations are behind the curve, as most countries only allow for two to three years for implementation, a supply chain expert cautions. Read More
Takeda Pharmaceuticals is selling off some of its drugs in Japan in exchange for stock in a new venture to be helmed by Teva Pharmaceutical Industries. Read More
Valeant’s access program with Walgreens, which the company says will make the company’s products affordable, is slated to kick off this Friday with dermatology brands, according to Ari Kellen, executive vice president and company group chairman. Read More
While 2014 and 2015 were years of megamergers in the pharmaceutical industry, a new report predicts that 2016 will give rise to a rather different competitive landscape, one where bigger is not necessarily better. Read More